A new Journal of the American Medical Association (JAMA) article highlights the Food and Drug Administration’s (FDA) Sentinel Initiative.  The JAMA Medical News & Perspectives piece focuses on the progress to date with Sentinel, which was designed to identify potential safety issues by using electronic data to evaluate the safety of marketed drugs, devices, and biologics. Sentinel’s coordinating center is located at the HPHC Institute and led by DPM Chair Richard Platt, MD, MS.